Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Depreciation and Depletion (2020 - 2025)

Historic Depreciation and Depletion for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to $1.0 million.

  • Cytek Biosciences' Depreciation and Depletion rose 1111.11% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 1176.47%. This contributed to the annual value of $3.5 million for FY2024, which is 2500.0% up from last year.
  • As of Q3 2025, Cytek Biosciences' Depreciation and Depletion stood at $1.0 million, which was up 1111.11% from $1.0 million recorded in Q2 2025.
  • Cytek Biosciences' Depreciation and Depletion's 5-year high stood at $1.0 million during Q2 2025, with a 5-year trough of $167000.0 in Q1 2021.
  • For the 5-year period, Cytek Biosciences' Depreciation and Depletion averaged around $616052.6, with its median value being $600000.0 (2023).
  • Per our database at Business Quant, Cytek Biosciences' Depreciation and Depletion skyrocketed by 19159.66% in 2021 and then changed by 0.0% in 2024.
  • Cytek Biosciences' Depreciation and Depletion (Quarter) stood at $347000.0 in 2021, then skyrocketed by 44.09% to $500000.0 in 2022, then skyrocketed by 60.0% to $800000.0 in 2023, then rose by 12.5% to $900000.0 in 2024, then increased by 11.11% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q3 2025, $1.0 million for Q2 2025, and $900000.0 during Q1 2025.